233 related articles for article (PubMed ID: 25187512)
1. Percutaneous injection of autologous bone marrow concentrate cells significantly reduces lumbar discogenic pain through 12 months.
Pettine KA; Murphy MB; Suzuki RK; Sand TT
Stem Cells; 2015 Jan; 33(1):146-56. PubMed ID: 25187512
[TBL] [Abstract][Full Text] [Related]
2. Treatment of discogenic back pain with autologous bone marrow concentrate injection with minimum two year follow-up.
Pettine K; Suzuki R; Sand T; Murphy M
Int Orthop; 2016 Jan; 40(1):135-40. PubMed ID: 26156727
[TBL] [Abstract][Full Text] [Related]
3. Autologous bone marrow concentrate intradiscal injection for the treatment of degenerative disc disease with three-year follow-up.
Pettine KA; Suzuki RK; Sand TT; Murphy MB
Int Orthop; 2017 Oct; 41(10):2097-2103. PubMed ID: 28748380
[TBL] [Abstract][Full Text] [Related]
4. Safety and tolerability of intradiscal implantation of combined autologous adipose-derived mesenchymal stem cells and hyaluronic acid in patients with chronic discogenic low back pain: 1-year follow-up of a phase I study.
Kumar H; Ha DH; Lee EJ; Park JH; Shim JH; Ahn TK; Kim KT; Ropper AE; Sohn S; Kim CH; Thakor DK; Lee SH; Han IB
Stem Cell Res Ther; 2017 Nov; 8(1):262. PubMed ID: 29141662
[TBL] [Abstract][Full Text] [Related]
5. Intradiscal injection therapy for degenerative chronic discogenic low back pain with end plate Modic changes.
Cao P; Jiang L; Zhuang C; Yang Y; Zhang Z; Chen W; Zheng T
Spine J; 2011 Feb; 11(2):100-6. PubMed ID: 20850390
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Effectiveness of Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Chronic Low Back Pain Due to Severe Lumbar Spinal Degeneration: A 12-Month, Open-Label, Prospective Controlled Trial.
Atluri S; Murphy MB; Dragella R; Herrera J; Boachie-Adjei K; Bhati S; Manocha V; Boddu N; Yerramsetty P; Syed Z; Ganjam M; Jain D; Syed Z; Grandhi N; Manchikanti L
Pain Physician; 2022 Mar; 25(2):193-207. PubMed ID: 35322978
[TBL] [Abstract][Full Text] [Related]
7. Intra-discal injection of autologous, hypoxic cultured bone marrow-derived mesenchymal stem cells in five patients with chronic lower back pain: a long-term safety and feasibility study.
Elabd C; Centeno CJ; Schultz JR; Lutz G; Ichim T; Silva FJ
J Transl Med; 2016 Sep; 14(1):253. PubMed ID: 27585696
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic mesenchymal precursor cells treatment for chronic low back pain associated with degenerative disc disease: a prospective randomized, placebo-controlled 36-month study of safety and efficacy.
Amirdelfan K; Bae H; McJunkin T; DePalma M; Kim K; Beckworth WJ; Ghiselli G; Bainbridge JS; Dryer R; Deer TR; Brown RD
Spine J; 2021 Feb; 21(2):212-230. PubMed ID: 33045417
[TBL] [Abstract][Full Text] [Related]
9. Autologous mesenchymal stromal cells embedded in tricalcium phosphate for posterolateral spinal fusion: results of a prospective phase I/II clinical trial with long-term follow-up.
Blanco JF; Villarón EM; Pescador D; da Casa C; Gómez V; Redondo AM; López-Villar O; López-Parra M; Muntión S; Sánchez-Guijo F
Stem Cell Res Ther; 2019 Feb; 10(1):63. PubMed ID: 30795797
[TBL] [Abstract][Full Text] [Related]
10. Human umbilical cord mesenchymal stem cell transplantation for the treatment of chronic discogenic low back pain.
Pang X; Yang H; Peng B
Pain Physician; 2014; 17(4):E525-30. PubMed ID: 25054402
[TBL] [Abstract][Full Text] [Related]
11. Bone Marrow-Derived Mesenchymal Stem Cells as Autologous Therapy in Dogs with Naturally Occurring Intervertebral Disc Disease: Feasibility, Safety, and Preliminary Results.
Steffen F; Smolders LA; Roentgen AM; Bertolo A; Stoyanov J
Tissue Eng Part C Methods; 2017 Nov; 23(11):643-651. PubMed ID: 28471303
[TBL] [Abstract][Full Text] [Related]
12. Pain Relief After Allogenic Stem Cell Disc Therapy.
Lewandrowski KU; Dowling A; Vera JC; Leon JFR; Telfeian AE; Lorio MP
Pain Physician; 2023 Mar; 26(2):197-206. PubMed ID: 36988365
[TBL] [Abstract][Full Text] [Related]
13. Treatment of lumbar degenerative disc disease-associated radicular pain with culture-expanded autologous mesenchymal stem cells: a pilot study on safety and efficacy.
Centeno C; Markle J; Dodson E; Stemper I; Williams CJ; Hyzy M; Ichim T; Freeman M
J Transl Med; 2017 Sep; 15(1):197. PubMed ID: 28938891
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells in lumbar spine surgery: a single institution experience about red bone marrow and fat tissue derived MSCs.
Piccirilli M; Delfinis CP; Santoro A; Salvati M
J Neurosurg Sci; 2017 Apr; 61(2):124-133. PubMed ID: 26082381
[TBL] [Abstract][Full Text] [Related]
15. Injections of concentrated bone marrow aspirate as treatment for Discogenic pain: a retrospective analysis.
Wolff M; Shillington JM; Rathbone C; Piasecki SK; Barnes B
BMC Musculoskelet Disord; 2020 Feb; 21(1):135. PubMed ID: 32111220
[TBL] [Abstract][Full Text] [Related]
16. The effect of spinal steroid injections for degenerative disc disease.
Buttermann GR
Spine J; 2004; 4(5):495-505. PubMed ID: 15363419
[TBL] [Abstract][Full Text] [Related]
17. [The DIAM spinal stabilisation system to treat degenerative disease of the lumbosacral spine].
Hrabálek L; Machác J; Vaverka M
Acta Chir Orthop Traumatol Cech; 2009 Oct; 76(5):417-23. PubMed ID: 19912707
[TBL] [Abstract][Full Text] [Related]
18. Symptomatic anterior cruciate ligament tears treated with percutaneous injection of autologous bone marrow concentrate and platelet products: a non-controlled registry study.
Centeno C; Markle J; Dodson E; Stemper I; Williams C; Hyzy M; Ichim T; Freeman M
J Transl Med; 2018 Sep; 16(1):246. PubMed ID: 30176875
[TBL] [Abstract][Full Text] [Related]
19. Intervertebral Disc Repair by Allogeneic Mesenchymal Bone Marrow Cells: A Randomized Controlled Trial.
Noriega DC; Ardura F; Hernández-Ramajo R; Martín-Ferrero MÁ; Sánchez-Lite I; Toribio B; Alberca M; García V; Moraleda JM; Sánchez A; García-Sancho J
Transplantation; 2017 Aug; 101(8):1945-1951. PubMed ID: 27661661
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous autologous bone marrow concentrate for knee osteoarthritis: patient-reported outcomes and progenitor cell content.
Centeno CJ; Berger DR; Money BT; Dodson E; Urbanek CW; Steinmetz NJ
Int Orthop; 2022 Oct; 46(10):2219-2228. PubMed ID: 35932306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
